Preventing Overdiagnosis Conference

To allow a treatment indication range and probabilities of benefit to be reviewed in an evidence-based way. The example reviewed is the current indication for treating diabetic microalbuminuria with an angiotensin receptor blocker (ARB) based on a baseline albumin excretion rate (AER) of 20 to 200mcg/min [1] providing an NNT of 13.1. ................
................

In order to avoid copyright disputes, this page is only a partial summary.